Benitec Biopharma appoints Ernst & Young as independent auditor for FY2027
BNTC•Benitec Biopharma engaged Ernst & Young as its independent registered public accounting firm for the fiscal year ending June 30, 2027. EY completed client acceptance procedures on Sept. 28, 2026, and the engagement letter was executed the next day.
1. Auditor appointment
Benitec Biopharma engaged Ernst & Young as its independent registered public accounting firm for the fiscal year ending June 30, 2027. EY completed its client acceptance procedures on Sept. 28, 2026, and the engagement letter was executed on Sept. 29.
